General Research



Jump to:



Page 7

Halberstadt (2016). Behavioral and pharmacokinetic interactions between monoamine oxidase inhibitors and the hallucinogen 5-methoxy-N,N-dimethyltryptamine. Pharmacology, Biochemistry, and Behavior.

Hardaway, Schweitzer & Suzuki (2016). Hallucinogen use disorders. Child and Adolescent Psychiatric Clinics of North America.

Howland (2016). Antidepressant, antipsychotic, and hallucinogen drugs for the treatment of psychiatric disorders: a convergence at the serotonin-2A receptor. Journal of Psychosocial Nursing & Mental Health Services.

Khilnani et al. (2016). Psychopharmacological dinner: A metaphoric learning of psychedelics from gustatory revelations of a pillbox. Indian Journal of Psychiatry.

Kleber (2016). The successful return of psychedelics to psychiatry. Journal of Psychopharmacology.

Langlitz (2016). Is there a place for psychedelics in philosophy?: Fieldwork in neuro- and perennial philosophy. Common Knowledge.

Letheby (2016). The epistemic innocence of psychedelic states. Consciousness and Cognition.

Lieberman & Shalev (2016). Back to the future: Research renewed on the clinical utility of psychedelic drugs. Journal of Psychopharmacology.

Martin & Nichols (2016). Psychedelics recruit multiple cellular types and produce complex transcriptional responses within the brain. EBioMedicine.

Mori & Suzuki (2016). The discriminative stimulus properties of hallucinogenic and dissociative anesthetic drugs. Current Topics in Behavioral Neurosciences.

Nesvag, Bramness & Ystrom (2016). The link between use of psychedelic drugs and mental health problems. Journal of Psychopharmacology.

Nichols (2016). Psychedelics. Pharmacological Reviews.

Nour et al. (2016). Ego-dissolution and psychedelics: Validation of the Ego-Dissolution Inventory (EDI). Frontiers in Human Neuroscience.

Noworyta-Sokolowska et al. (2016). Synthetic hallucinogen 5-methoxy-N,N-diisopropyltryptamine and its action in the rat brain. European Neuropsychopharmacology.

Orsolini et al. (2016). The "Endless Trip": Psychopathology and psychopharmacology in the Hallucinogen Persisting Perception Disorder (HPPD). European Psychiatry.

Papo (2016). Commentary: The entropic brain: a theory of conscious states informed by neuroimaging research with psychedelic drugs. Frontiers in Human Neuroscience.

Rhead (2016). How to best support an important renaissance in psychology. PsycCRITIQUES.

Riba (2016). Neurophysiological effects of psychedelics in humans. European Neuropsychopharmacology.

Roberts (2016). The entheogen reformation. Journal of Transpersonal Psychology.

Rucker et al. (2016). Psychedelics in the treatment of unipolar mood disorders: a systematic review. Journal of Psychopharmacology.

Schleking (2016). Psychedelic fears: drug use as an emotional practice in West Germany around 1970. Storicamente.

Strauss et al. (2016). Australia should be initiating a psychedelic research program: What are the barriers? The Australian and New Zealand Journal of Psychiatry.

Vejmola et al. (2016). Quantitative EEG study of serotonergic hallucinogens in rats − the relationship of brain activity and behavior. European Neuropsychopharmacology.

Walsh (2016). Psychedelics and cognitive liberty: Reimagining drug policy through the prism of human rights. International Journal of Drug Policy.

Walsh et al. (2016). Hallucinogen use and intimate partner violence: Prospective evidence consistent with protective effects among men with histories of problematic substance use. Journal of Psychopharmacology.

Weinel (2016). Entoptic phenomena in audio: categories of psychedelic electroacoustic composition. Contemporary Music Review.

Winkelman (2016). Psychedelics and mystical experiences. PsycCRITIQUES.

Al-lmam (2017).  Could hallucinogens induce permanent pupillary changes in (ab)users? a case report from New Zealand. Case Reports in Neurological Medicine.

Argento et al. (2017). Does psychedelic drug use reduce risk of suicidality? Evidence from a longitudinal community-based cohort of marginalised women in a Canadian setting. BMJ Open.

Barrett & Griffiths (2017). The factor structure of the Mystical Experience Questionnaire (MEQ): Reply to Bouso et al., 2016. Human Psychopharmacology.

Barrett et al. (2017). Qualitative and quantitative features of music reported to support peak mystical experiences during psychedelic therapy sessions. Frontiers in Psychology.

Bøhling (2017). Psychedelic pleasures: An affective understanding of the joys of tripping. The International Journal on Drug Policy.

Bright, Williams & Caldicott (2017). Should addiction researchers be interested in psychedelic science? Drug and Alcohol Review.

Calderon, Hunt & Klein (2017). A regulatory perspective on the evaluation of hallucinogen drugs for human use. Neuropharmacology.

Carhart-Harris & Goodwin (2017). The Therapeutic Potential of Psychedelic Drugs: Past, Present, and Future. Neuropsychopharmacology.

Carhart-Harris & Nutt (2017). Serotonin and brain function: a tale of two receptors. Journal of Psychopharmacology.

Carhart-Harris et al. (2017). Psychedelics and connectedness. Psychopharmacology.

Elsey (2017). Psychedelic drug use in healthy individuals: A review of benefits, costs, and implications for drug policy. Drug Science, Policy and Law.

Erritzoe & Richards (2017). Lessons to be learned from early psychedelic therapy in Denmark. Nordic Journal of Psychiatry.

Faktorovich (2017). The World Is About to End! Let's Do Drugs! Pennsylvania Literary Journal.

Forstmann & Sagioglou (2017). Lifetime experience with (classic) psychedelics predicts pro-environmental behavior through an increase in nature relatedness. Journal of Psychopharmacology.

Garcia-Romeu, Griffiths & Johnson (2017). Psychedelic-associated addiction remission: An online survey. Drug and Alcohol Dependence.

Grob & Bossis (2017). Humanistic psychology, psychedelics, and the transpersonal vision. Journal of Humanistic Psychology.

Hendricks, Lappan & Cropsey (2017). Hallucinogen use is associated with a decreased likelihood of positive urine drug screen following entry into community corrections supervision. Drug and Alcohol Dependence.

Idell et al. (2017). The fibrinolytic system: A new target for treatment of depression with psychedelics. Medical Hypotheses.

Johnson et al. (2017). An online survey of tobacco smoking cessation associated with naturalistic psychedelic use. Journal of Psychopharmacology.

Kraehenmann (2017). Dreams and psychedelics: Neurophenomenological comparison and therapeutic implications. Current Neuropharmacology.

Krippner (2017). Ecstatic landscapes: The manifestation of psychedelic art. The Journal of Humanistic Psychology.

Letheby & Gerrans (2017). Self unbound: ego dissolution in psychedelic experience. Neuroscience of Consciousness.

Lev-Ran et al. (2017). Comparing triggers to visual disturbances among individuals with positive vs negative experiences of hallucinogen-persisting perception disorder (HPPD) following LSD use. The American Journal on Addictions.

Marinova et al. (2017). The hallucinogen 2,5-dimethoxy-4-iodoamphetamine hydrochloride activates neurotrophin receptors in a neuronal cell line and promotes neurites extension. Journal of Neural Transmission.

Metzner (2017). Entheogenesis: Toward an expanded worldview for our time. Journal of Humanistic Psychology.

Millière (2017). Looking for the self: Phenomenology, neurophysiology and philosophical significance of drug-induced ego dissolution. Frontiers in Human Neuroscience.

Nichols, Johnson & Nichols (2017). Psychedelics as medicines: An emerging new paradigm. Clinical Pharmacology & Therapeutics.

Nichols (2017). Addressing the need for rigor in the rebirth of hallucinogen research. Drugs and Alcohol Dependence.

Nour, Evans & Carhart-Harris (2017). Psychedelics, personality and political perspectives. Journal of Psychoactive Drugs.

Orsolini et al. (2017). The "endless trip" among the NPS users: psychopathology and psychopharmacology in the hallucinogen-persisting perception disorder. a systematic review. Frontiers in Psychiatry.

Palamar et al. (2017). Assessing self-reported use of new psychoactive substances: The impact of gate questions. The American Journal of Drug and Alcohol Abuse.

Phelps (2017). Developing guidelines and competencies for the training of psychedelic therapists. Drug and Alcohol Dependence.

Pisano et al. (2017). The association of psychedelic use and opioid use disorders among illicit users in the United States. Journal of Psychopharmacology.

Puspanathan (2017). Psychedelic research in Australia: Breaking through the stigma. The Australian and New Zealand Journal of Psychiatry.

Richards (2017). Psychedelic psychotherapy: Insights from 25 years of research. The Journal of Humanistic Psychology.

Richards (2017). Abraham Maslow's interest in psychedelic research: A tribute. The Journal of Humanistic Psychology.

Roy-Byrne (2017). Reviews of note: A future for psychedelic psychiatry? NEJM Journal Watch. Psychiatry.

Rucker, Iliff & Nutt (2017). Psychiatry & the psychedelic drugs. Past, present & future. Neuropharmacology.

Sellers, Romach & Leiderman (2017). Studies with psychedelic drugs in human volunteers. Neuropharmacology.

Vargas-Perez et al. (2018). A single administration of the hallucinogen, 4-acetoxy-dimethyltryptamine, prevents the shift to a drug-dependent state and the expression of withdrawal aversions in rodents. The European Journal of Neuroscience.

Winkelman (2017). The mechanisms of psychedelic visionary experiences: hypotheses from evolutionary psychology. Frontiers in Neuroscience.

Yaden et al. (2017). Of roots and fruits: A comparison of psychedelic and nonpsychedelic mystical experiences. The Journal of Humanistic Psychology.